Bringing Artificial Intelligence to End-to-End Quality Management Systems

As the use of AI becomes more widespread, drug and device developers are wondering how it can be leveraged to improve their processes. Pharma Ignite, in partnership with IQVIA Technologies, takes you inside the key considerations for using AI to augment and enhance QMS, with the aim of keeping developers in compliance and ensuring patient safety.

Learn more now about:

The state of QMS today
Necessary elements for an effective QMS
How AI can be used to streamline time-consuming QM tasks
Understanding what AI can – and cannot – do within a QMS
The role of humans in AI augmented systems
Overcoming the barriers to AI adoption to reap the rewards of improved quality operations

Download the Whitepaper

Your company email address

Please select your industry: (max 1)
I would like to hear more from an IQVIA expert

Opt In?

Berne Media may store and process my information. For details, see the Privacy Notice.
Citeline (previously Pharma Intelligence UK) may contact me with updates, relevant promotions and information about products. My Information will be used in accordance with the Citeline Privacy Policy, and you withdraw your permission to receive any of our communications at any time.
By clicking submit, you consent to allow IQVIA Technologies to store and process the information submitted to provide you the content requested. They are subject to IQVIA Technologies's Privacy Policy.

Please complete all required fields to access the content!

Future-Ready Pharmacovigilance: Integrating AI With FDA's EDSTP Guidelines

Join IQVIA’s esteemed panel of experts for an in-depth discussion on how AI can meet and exceed these new expectations. This webinar delves into the intersection of regulatory frameworks and technological innovation, offering insights into the future of PV and how organizations can navigate this transformative field. Key takeaways include:

Accelerating Biologics Development With Strategies For Success

The biologics market is growing rapidly, unlocking exciting opportunities but also presenting significant challenges. Developers are undergoing pressure to accelerate the delivery of innovative therapies while addressing complex regulatory demands, navigating demanding clinical trial phases, efficiently scaling production, and maintaining quality. In this webinar, industry experts will share practical strategies and real-world examples to help you navigate these challenges. Key takeaways:

A New Era of Participant Payment Services

Financial burdens are cited as one of the main barriers to clinical trial recruitment and retention, with traditional methods proving unreliable, complicated and slow. For trial sites and sponsors, the administration burden can be overwhelming, especially on a global scale. Discover how IQVIA’s Participant Payment service is transforming the participant payment landscape, simplifying the process and driving clinical trial success, by offering: